Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
6
5
0
INVITAE CORP
Share · US46185L1035 · NVTA · A14NKG (XNYS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INVITAE CORP
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 99,26 %
Shares Float 284,38 M
Shares Outstanding 286,49 M
Company Profile for INVITAE CORP Share
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Company Data
Name INVITAE CORP
Company Invitae Corporation
Symbol NVTA
Website
https://www.invitae.com
Primary Exchange 
NYSE
NYSE
WKN A14NKG
ISIN US46185L1035
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Kenneth D. Knight
Country United States of America
Currency USD
Employees 1,7 T
Address 1400 16th Street, 94103 San Francisco
IPO Date 2015-02-12
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | NVTAQ |
| London | 0JDB.L |
| NYSE | NVTA |
More Shares
Investors who hold INVITAE CORP also have the following shares in their portfolio:
